Single Center Clinical Experience With Radium-223 Dichloride In Patients With Metastatic Castrate-resistant Prostate Cancer

被引：0
|
作者：
Tiskevicius, S. [1 ]
Vidrinskaite, A. [1 ]
Stalnionis, M. [1 ]
机构：
[1] Natl Canc Inst, Vilnius, Lithuania
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0683
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [1] A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Charrois-Durand, Cedric
    Saad, Fred
    Barkati, Maroie
    Lattouf, Jean-Baptiste
    Perrotte, Paul
    Karakiewicz, Pierre, I
    Soulieres, Denis
    Blais, Normand
    Hamilou, Zineb
    Juneau, Daniel
    Plouznikoff, Nicolas
    Taussky, Daniel
    Delouya, Guila
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (06): : 199 - 205
  • [2] Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Zhang, Isabella
    Gilbo, Philip
    Kohn, Nina
    Cox, Brett
    [J]. PRACTICAL RADIATION ONCOLOGY, 2018, 8 (06) : 452 - 457
  • [3] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [4] One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer
    Jadvar, Hossein
    Challa, Sudha
    Quinn, David I.
    Conti, Peter S.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (05) : 195 - 199
  • [5] Single-Institution Experience With Radium-223 Dichloride (Ra-223) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Cox, B. W.
    Wang, L.
    Bradley, T.
    Gu, B.
    Kelley, K.
    Potters, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S470 - S470
  • [6] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [7] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [8] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [9] Parameters Associated With 6 Cycles of Radium-223 Dichloride Therapy in Metastatic Castrate-Resistant Prostate Cancer
    Stolten, M. D.
    Steinberger, A. E.
    Cotogno, P. M.
    Ledet, E. M.
    Lewis, B. E.
    Sartor, O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E196 - E196
  • [10] The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride
    Randhawa, M.
    Jones, R.
    Stratton, I.
    Bahl, A.
    Bottomley, D.
    Carruthers, H.
    [J]. CLINICAL ONCOLOGY, 2019, 31 (02) : E24 - E24
12345